Document is current

Any future updates will be listed below

Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera

Crossref DOI link: https://doi.org/10.1007/s00277-014-2247-1

Published Online: 2014-11-09

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark